PHYSIOMICS (PYC)

 

Latest News

Prof. Mark Middleton appointed to Physiomics SAB

RNS Number: 9498U Physiomics PLC 04 August 2015 Physiomics plc ("Physiomics") or ("the Company") Professor Mark Middleton appointed to Physiomics SAB Physiomics plc (AIM: PYC), the Oxford, UK based systems biology company, is pleased to announce that it has appointed Professor Mark Middleton to its Scientific Advisory Board. Professor Middleton is P...

Holding(s) in Company

RNS Number: 7476L Physiomics PLC 29 April 2015 TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES i 1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: ii Physiomics 2 Reason for the notification (please tick the appropriate box or boxes): An acquisition or disposal of voting rights X An acquisition or dispo...

Virtual Tumour platform - AACR Annual Meeting 2015

RNS Number: 8910K Physiomics PLC 22 April 2015 Physiomics plc ("Physiomics") or ("the Company") Physiomics to present new developments of the Virtual Tumour platform in immunotherapy at Annual Meeting for American Association for Cancer Research ("AACR") Physiomics plc (AIM: PYC), the Oxford, UK based systems biology company, is pleased to a...

Virtual Tumour platform - AACR Annual Meeting 2015

RNS Number: 8910K Physiomics PLC 22 April 2015 Physiomics plc ("Physiomics") or ("the Company") Physiomics to present new developments of the Virtual Tumour platform in immunotherapy at Annual Meeting for American Association for Cancer Research ("AACR") Physiomics plc (AIM: PYC), the Oxford, UK based systems biology company, is pleased to a...

All News

DateHeadlineSource
04-08-15Prof. Mark Middleton appointed to Physiomics SABRNS
29-04-15Holding(s) in CompanyRNS
22-04-15Virtual Tumour platform - AACR Annual Meeting 2015RNS
22-04-15Virtual Tumour platform - AACR Annual Meeting 2015RNS
26-03-15Issue of OptionsRNS
17-03-15Half Yearly ReportRNS
12-03-15Issue of EquityRNS
06-03-15Holding(s) in CompanyRNS
04-03-15Holding(s) in CompanyRNS
03-03-15FTSE ends lower as blue-chip trinity weighsStockMarketWire
03-03-15Physiomics' dealStockMarketWire
03-03-15First contract for clinical version of VirtuRNS
20-02-15Holding(s) in CompanyRNS
02-02-15Termination of Equity Swap AgreementRNS
15-12-14Result of AGMRNS
17-11-14FTSE falls as Astrazeneca, financials slip lowerStockMarketWire
12-11-14Operating losses fall at PhysiomicsStockMarketWire
12-11-14Final ResultsRNS
04-11-14FTSE up on financials as oily stocks feel Saudi pinchStockMarketWire
04-11-14Disclosure of Large Pharma partner Merck & CoRNS
27-10-14Physiomics extends deal with pharma partnerStockMarketWire
27-10-14Project extension with global pharma companyRNS
13-10-14Holding(s) in CompanyRNS
07-10-14Cardiotox Platform LaunchRNS
29-08-14Holding(s) in CompanyRNS
14-08-14Physiomics wins new deal with global pharmaStockMarketWire
14-08-14New deal with global pharmaRNS
24-07-14Physiomics raises up to £562,500StockMarketWire
24-07-14Issue of EquityRNS
26-06-14Holding(s) in CompanyRNS
12-06-14Physiomics in anticipated new collaboration with DiatechStockMarketWire
12-06-14Anticipated new collaboration with DiatechRNS
20-05-14Holding(s) in CompanyRNS
10-04-14Second validation of Virtual Tumour ClinicalRNS
03-04-14Virtual Tumour Clinical ValidationRNS
14-02-14Physiomics narrows H1 pretax loss to £0.21mStockMarketWire
14-02-14Half Yearly ReportRNS
30-01-14Issue of Equity - ReplacementRNS
30-01-14Physiomics issues shares under SEDAStockMarketWire
30-01-14Issue of EquityRNS

RSS feeds

  • Editorial news feed for LSE:PYC Editorial
  • Regulatory news feed for LSE:PYC Regulatory